Trials / Completed
CompletedNCT01018771
Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion
A Prospective, Randomised Study Comparing the Use of Actifuse (Trademark) Advanced Bone Matrix (ABX) Synthetic Bone Substitute With INFUSE (Trademark) on Fusion in Patients Requiring Posterolateral Instrumented Lumbar Fusion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective randomised study. Primary objective: Evaluation of success rates of Actifuse ABX and INFUSE in achieving bone fusion. Secondary objectives: Assess clinical outcome measurements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Actifuse ABX | bone graft to be used in posterolateral instrumented lumbar fusion |
| PROCEDURE | INFUSE, plus Mastergraft granules | bone graft to be used in posterolateral instrumented lumbar fusion |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2009-11-25
- Last updated
- 2017-04-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01018771. Inclusion in this directory is not an endorsement.